pyrazines has been researched along with pyrazolopyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiello, R; Aspnes, GE; Atkinson, K; Baker, L; Barucci, N; Bian, J; Bourassa, P; Bourbonais, F; Bourbounais, F; D'Aquila, T; Derksen, DR; Filipski, KJ; Guzman-Perez, A; Hamilton, M; Hank, R; Jones, CS; Karki, K; Li, JC; Litchfield, J; MacDougall, M; Patel, L; Pfefferkorn, JA; Rasmusson, T; Robertson, A; Sammons, MF; Song, W; Tu, M; Zeng, D | 1 |
| Ding, K; Li, X; Long, H; Lu, X; Luo, J; Shen, J; Tu, Z; Zhang, Z; Zhou, X | 1 |
2 other study(ies) available for pyrazines and pyrazolopyridine
| Article | Year |
|---|---|
The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitus.
Topics: Administration, Oral; Animals; Cell Line, Tumor; Diabetes Mellitus, Type 2; Drug Design; Glucokinase; Glucose Tolerance Test; Half-Life; Humans; Hypoglycemic Agents; Indazoles; Insulin; Kinetics; Protein Binding; Pyrazines; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2012 |
3-aminopyrazolopyrazine derivatives as spleen tyrosine kinase inhibitors.
Topics: Binding Sites; Cell Line, Tumor; Cell Proliferation; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyrazines; Pyrazoles; Pyridines; Signal Transduction; Spleen; Structure-Activity Relationship; Syk Kinase | 2016 |